Potential immunotherapies for traumatic brain and spinal cord injury.
10.1016/j.cjtee.2018.02.002
- Author:
Raj PUTATUNDA
1
;
John R BETHEA
2
;
Wen-Hui HU
3
Author Information
1. Center for Metabolic Disease Research, Department of Pathology and Laboratory Medicine, Temple University Lewis Katz School of Medicine, 3500 N Broad Street, Philadelphia, PA, USA.
2. Department of Biology, Drexel University, Philadelphia, PA, USA.
3. Center for Metabolic Disease Research, Department of Pathology and Laboratory Medicine, Temple University Lewis Katz School of Medicine, 3500 N Broad Street, Philadelphia, PA, USA. Electronic address: whu@temple.edu.
- Publication Type:Journal Article
- Keywords:
Brain injury;
Immunotherapy;
Inflammatory response;
Innate and adaptive immunity;
Secondary injury;
Spinal cord injury
- MeSH:
Adaptive Immunity;
Astrocytes;
physiology;
Brain Injuries, Traumatic;
immunology;
therapy;
Histone Deacetylases;
therapeutic use;
Humans;
Immunity, Innate;
immunology;
Immunotherapy;
methods;
Inflammasomes;
drug effects;
physiology;
Macrophage Activation;
Spinal Cord Injuries;
immunology;
therapy
- From:
Chinese Journal of Traumatology
2018;21(3):125-136
- CountryChina
- Language:English
-
Abstract:
Traumatic injury of the central nervous system (CNS) including brain and spinal cord remains a leading cause of morbidity and disability in the world. Delineating the mechanisms underlying the secondary and persistent injury versus the primary and transient injury has been drawing extensive attention for study during the past few decades. The sterile neuroinflammation during the secondary phase of injury has been frequently identified substrate underlying CNS injury, but as of now, no conclusive studies have determined whether this is a beneficial or detrimental role in the context of repair. Recent pioneering studies have demonstrated the key roles for the innate and adaptive immune responses in regulating sterile neuroinflammation and CNS repair. Some promising immunotherapeutic strategies have been recently developed for the treatment of CNS injury. This review updates the recent progress on elucidating the roles of the innate and adaptive immune responses in the context of CNS injury, the development and characterization of potential immunotherapeutics, as well as outstanding questions in this field.
